Xaira, an AI drug discovery startup, launches with a massive $1B, says it's 'ready' to start developing drugs | TechCrunch

University of Washington's models, similar to OpenAI's, focus on designing molecular structures for physical creation in Xaira Therapeutics.

Generative AI in biology is still in early stages, with the need to create datasets driving model development, unlike tech where data is consumer-generated.

Read at TechCrunch